Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: diversity in clinical trials

Patient Recruitment and Retention in Clinical Trials: Strategies for Successful Enrollment and Long-Term Engagement

Posted on May 15, 2025 digi By digi

Patient Recruitment and Retention in Clinical Trials: Strategies for Successful Enrollment and Long-Term Engagement Essential Strategies for Enhancing Patient Recruitment and Retention in Clinical Trials Patient recruitment and retention are among the most critical—and most challenging—aspects of clinical trial success. Timely enrollment and sustained participant engagement directly impact study timelines, data quality, regulatory approval, and…

Read More “Patient Recruitment and Retention in Clinical Trials: Strategies for Successful Enrollment and Long-Term Engagement” »

Patient Recruitment and Retention

Diversity and Inclusion in Clinical Trials: Strategies for Building Representative Research

Posted on May 13, 2025 digi By digi

Diversity and Inclusion in Clinical Trials: Strategies for Building Representative Research Empowering Diversity and Inclusion in Clinical Trials for Better Health Outcomes Building diversity and inclusion into clinical trials is no longer just a moral imperative—it is a scientific, regulatory, and public health necessity. Representative trial populations ensure that study results are applicable to all…

Read More “Diversity and Inclusion in Clinical Trials: Strategies for Building Representative Research” »

Diversity and Inclusion in Trials, Patient Recruitment and Retention

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
  • Clinical Trial Design and Protocol Development
  • Good Clinical Practice (GCP) and Compliance
  • U.S. FDA Regulations

Menu

Recent Posts

  • Managing High-Volume Data from Phase 3 Trials: Systems, Processes, and Best Practices
  • Microtracer and AMS Techniques in Early Human PK Studies
  • Statistical Simulation Models in Dose Optimization
  • Pharmacogenomics in Phase 4 Clinical Trials: Identifying Risk Populations Through Genetic Insights
  • Post-Hoc Analyses and Subgroup Evaluation in Phase 3 Clinical Trials: Purpose, Pitfalls, and Strategic Applications

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme